Position in PCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,022,065
-$2,110,864 QoQ
Shares Held
79,703
-56.4% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $156,689,854 across 37 Drug Manufacturers - Specialty & Generic names. PCRX ranks #16 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
178,605 | $30,102,086 | |
| 2 | ZTS |
Zoetis Inc.
|
200,280 | $14,392,120 | |
| 3 | VTRS |
Viatris Inc
|
849,694 | $13,493,139 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
262,336 | $10,763,646 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
424,167 | $10,438,749 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
216,865 | $10,251,208 | |
| 7 | LQDA |
Liquidia Corp
|
122,836 | $9,793,714 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
16,798 | $9,101,659 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,022,065 | 79,703 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,132,929 | 182,873 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $4,153,041 | 160,473 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,851,274 | 149,448 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,833,799 | 76,728 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,844,565 | 74,228 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,788,525 | 254,168 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $6,689,032 | 444,454 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $5,917,262 | 206,825 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,392,357 | 81,874 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $2,011,072 | 59,605 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,689,731 | 55,076 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,303,984 | 57,499 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,854,569 | 45,444 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,799,070 | 46,596 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,598,117 | 48,846 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $2,842,357 | 48,754 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $3,727,238 | 48,837 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,966,559 | 49,303 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,698,304 | 48,184 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,943,646 | 48,511 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,579,635 | 51,072 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,015,694 | 50,396 | Shares | Defined | 2021-08-16 | |
| 2020-09-30 | $13,827 | 230 | Shares | Defined | 2021-08-05 | |
| 2020-06-30 | $8,451,185 | 161,067 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,963,680 | 148,037 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||